
Are you feeling lost on the road to automation? Visit Booth 39 at PHUSE EU to meet with our experts who can assess your current state and give you a step-by-step plan for automation excellence.
Our team is dedicated to industry innovation, especially within the open source community. We endorse the use of open source programming and are actively contributing to the open source community, releasing projects that will increase efficiencies and spur further innovation across the bio-pharmaceutical industry.
Book in a meeting with one of our experts attending PHUSE EU to find out how we can help with your clinical study.
For more information on our Automation capabilities, download the brochure below.
Presentations

An Experiment on the Use of Altair SLC for Clinical Study Analytics
Mark Holland, Head of Programming Delivery
Monday 11:30 – 12 (TT03)

It’s Not the Destination, it’s the Journey: Unlocking Growth and Realising Potential with Continuing Professional Development
Diana Stuart, Director, Professional Development
Monday 12 – 13:30 & Wednesday 11:30 – 12, (PD10)

Data Pipelines in Clinical Trials Leveraging Apache Airflow for Automated Task Management
Kostiantyn Zvieriev, Senior Programmer I
Monday 13:30 – 14 (SM04)

End-to-end Automation Using a Model-Driven Development (MDD) Workbench
Stuart Malcolm, Head of Standards, Efficiency and Automation

Interactive Reporting Using FDA Standard Safety Shells and the CDISC Analysis Results Standard
Megan Harries, Programmer II
Tuesday 16 – 16:30 (DV05)
About Veramed
People. Data. Analysis. Decisions.
Veramed is a pioneering CRO redefining intelligent healthcare decision-making through end-to-end biometrics. We bring together people, innovation, and technology together with world-class governance to accelerate evidence generation and advance patient health. With skilled Statisticians, Programmers and Data Managers uniquely matched and scaled to client needs, we produce exceptional deliverables swiftly using a blend of skill, rigorous governance, and automation to optimize the speed and success of clinical research from design to submission and beyond.